Back to Search
Start Over
Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics.
- Source :
-
Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2024 May; Vol. 14 (5), pp. 2349-2357. Date of Electronic Publication: 2024 Mar 06. - Publication Year :
- 2024
-
Abstract
- A titrant for the SARS-CoV-2 main protease (M <superscript>pro</superscript> ) was developed that enables, for the first time, the exact determination of the concentration of the enzymatically active M <superscript>pro</superscript> by active-site titration. The covalent binding mode of the tetrapeptidic titrant was elucidated by the determination of the crystal structure of the enzyme-titrant complex. Four fluorogenic substrates of M <superscript>pro</superscript> , including a prototypical, internally quenched Dabcyl-EDANS peptide, were compared in terms of solubility under typical assay conditions. By exploiting the new titrant, key kinetic parameters for the M <superscript>pro</superscript> -catalyzed cleavage of these substrates were determined.<br />Competing Interests: The authors declare no conflicts of interest.<br /> (© 2024 The Authors.)
Details
- Language :
- English
- ISSN :
- 2211-3835
- Volume :
- 14
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Acta pharmaceutica Sinica. B
- Publication Type :
- Academic Journal
- Accession number :
- 38799620
- Full Text :
- https://doi.org/10.1016/j.apsb.2024.03.001